1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Hypersomnia Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Provigil 1.2.3 Xyrem 1.2.4 Others 1.3 Market by Application 1.3.1 Global Hypersomnia Drug Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital Pharmacies 1.3.3 Retail Pharmacies 1.3.4 Online Pharmacies 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Hypersomnia Drug Market Perspective (2016-2027) 2.2 Hypersomnia Drug Growth Trends by Regions 2.2.1 Hypersomnia Drug Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Hypersomnia Drug Historic Market Share by Regions (2016-2021) 2.2.3 Hypersomnia Drug Forecasted Market Size by Regions (2022-2027) 2.3 Hypersomnia Drug Industry Dynamic 2.3.1 Hypersomnia Drug Market Trends 2.3.2 Hypersomnia Drug Market Drivers 2.3.3 Hypersomnia Drug Market Challenges 2.3.4 Hypersomnia Drug Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Hypersomnia Drug Players by Revenue 3.1.1 Global Top Hypersomnia Drug Players by Revenue (2016-2021) 3.1.2 Global Hypersomnia Drug Revenue Market Share by Players (2016-2021) 3.2 Global Hypersomnia Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Hypersomnia Drug Revenue 3.4 Global Hypersomnia Drug Market Concentration Ratio 3.4.1 Global Hypersomnia Drug Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Hypersomnia Drug Revenue in 2020 3.5 Hypersomnia Drug Key Players Head office and Area Served 3.6 Key Players Hypersomnia Drug Product Solution and Service 3.7 Date of Enter into Hypersomnia Drug Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Hypersomnia Drug Breakdown Data by Type 4.1 Global Hypersomnia Drug Historic Market Size by Type (2016-2021) 4.2 Global Hypersomnia Drug Forecasted Market Size by Type (2022-2027) 5 Hypersomnia Drug Breakdown Data by Application 5.1 Global Hypersomnia Drug Historic Market Size by Application (2016-2021) 5.2 Global Hypersomnia Drug Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Hypersomnia Drug Market Size (2016-2027) 6.2 North America Hypersomnia Drug Market Size by Type 6.2.1 North America Hypersomnia Drug Market Size by Type (2016-2021) 6.2.2 North America Hypersomnia Drug Market Size by Type (2022-2027) 6.2.3 North America Hypersomnia Drug Market Size by Type (2016-2027) 6.3 North America Hypersomnia Drug Market Size by Application 6.3.1 North America Hypersomnia Drug Market Size by Application (2016-2021) 6.3.2 North America Hypersomnia Drug Market Size by Application (2022-2027) 6.3.3 North America Hypersomnia Drug Market Size by Application (2016-2027) 6.4 North America Hypersomnia Drug Market Size by Country 6.4.1 North America Hypersomnia Drug Market Size by Country (2016-2021) 6.4.2 North America Hypersomnia Drug Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Hypersomnia Drug Market Size (2016-2027) 7.2 Europe Hypersomnia Drug Market Size by Type 7.2.1 Europe Hypersomnia Drug Market Size by Type (2016-2021) 7.2.2 Europe Hypersomnia Drug Market Size by Type (2022-2027) 7.2.3 Europe Hypersomnia Drug Market Size by Type (2016-2027) 7.3 Europe Hypersomnia Drug Market Size by Application 7.3.1 Europe Hypersomnia Drug Market Size by Application (2016-2021) 7.3.2 Europe Hypersomnia Drug Market Size by Application (2022-2027) 7.3.3 Europe Hypersomnia Drug Market Size by Application (2016-2027) 7.4 Europe Hypersomnia Drug Market Size by Country 7.4.1 Europe Hypersomnia Drug Market Size by Country (2016-2021) 7.4.2 Europe Hypersomnia Drug Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Hypersomnia Drug Market Size (2016-2027) 8.2 Asia-Pacific Hypersomnia Drug Market Size by Type 8.2.1 Asia-Pacific Hypersomnia Drug Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Hypersomnia Drug Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Hypersomnia Drug Market Size by Type (2016-2027) 8.3 Asia-Pacific Hypersomnia Drug Market Size by Application 8.3.1 Asia-Pacific Hypersomnia Drug Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Hypersomnia Drug Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Hypersomnia Drug Market Size by Application (2016-2027) 8.4 Asia-Pacific Hypersomnia Drug Market Size by Region 8.4.1 Asia-Pacific Hypersomnia Drug Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Hypersomnia Drug Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Hypersomnia Drug Market Size (2016-2027) 9.2 Latin America Hypersomnia Drug Market Size by Type 9.2.1 Latin America Hypersomnia Drug Market Size by Type (2016-2021) 9.2.2 Latin America Hypersomnia Drug Market Size by Type (2022-2027) 9.2.3 Latin America Hypersomnia Drug Market Size by Type (2016-2027) 9.3 Latin America Hypersomnia Drug Market Size by Application 9.3.1 Latin America Hypersomnia Drug Market Size by Application (2016-2021) 9.3.2 Latin America Hypersomnia Drug Market Size by Application (2022-2027) 9.3.3 Latin America Hypersomnia Drug Market Size by Application (2016-2027) 9.4 Latin America Hypersomnia Drug Market Size by Country 9.4.1 Latin America Hypersomnia Drug Market Size by Country (2016-2021) 9.4.2 Latin America Hypersomnia Drug Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Hypersomnia Drug Market Size (2016-2027) 10.2 Middle East & Africa Hypersomnia Drug Market Size by Type 10.2.1 Middle East & Africa Hypersomnia Drug Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Hypersomnia Drug Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Hypersomnia Drug Market Size by Type (2016-2027) 10.3 Middle East & Africa Hypersomnia Drug Market Size by Application 10.3.1 Middle East & Africa Hypersomnia Drug Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Hypersomnia Drug Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Hypersomnia Drug Market Size by Application (2016-2027) 10.4 Middle East & Africa Hypersomnia Drug Market Size by Country 10.4.1 Middle East & Africa Hypersomnia Drug Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Hypersomnia Drug Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Teva 11.1.1 Teva Company Details 11.1.2 Teva Business Overview 11.1.3 Teva Hypersomnia Drug Introduction 11.1.4 Teva Revenue in Hypersomnia Drug Business (2016-2021) 11.1.5 Teva Recent Development 11.2 Jazz Pharmaceuticals 11.2.1 Jazz Pharmaceuticals Company Details 11.2.2 Jazz Pharmaceuticals Business Overview 11.2.3 Jazz Pharmaceuticals Hypersomnia Drug Introduction 11.2.4 Jazz Pharmaceuticals Revenue in Hypersomnia Drug Business (2016-2021) 11.2.5 Jazz Pharmaceuticals Recent Development 11.3 BIOPROJET 11.3.1 BIOPROJET Company Details 11.3.2 BIOPROJET Business Overview 11.3.3 BIOPROJET Hypersomnia Drug Introduction 11.3.4 BIOPROJET Revenue in Hypersomnia Drug Business (2016-2021) 11.3.5 BIOPROJET Recent Development 11.4 AVADEL PHARMACEUTICALS 11.4.1 AVADEL PHARMACEUTICALS Company Details 11.4.2 AVADEL PHARMACEUTICALS Business Overview 11.4.3 AVADEL PHARMACEUTICALS Hypersomnia Drug Introduction 11.4.4 AVADEL PHARMACEUTICALS Revenue in Hypersomnia Drug Business (2016-2021) 11.4.5 AVADEL PHARMACEUTICALS Recent Development 11.5 GlaxoSmithKline 11.5.1 GlaxoSmithKline Company Details 11.5.2 GlaxoSmithKline Business Overview 11.5.3 GlaxoSmithKline Hypersomnia Drug Introduction 11.5.4 GlaxoSmithKline Revenue in Hypersomnia Drug Business (2016-2021) 11.5.5 GlaxoSmithKline Recent Development 11.6 Pfizer 11.6.1 Pfizer Company Details 11.6.2 Pfizer Business Overview 11.6.3 Pfizer Hypersomnia Drug Introduction 11.6.4 Pfizer Revenue in Hypersomnia Drug Business (2016-2021) 11.6.5 Pfizer Recent Development 11.7 Theranexus 11.7.1 Theranexus Company Details 11.7.2 Theranexus Business Overview 11.7.3 Theranexus Hypersomnia Drug Introduction 11.7.4 Theranexus Revenue in Hypersomnia Drug Business (2016-2021) 11.7.5 Theranexus Recent Development 11.8 Fisher & Paykel Healthcare 11.8.1 Fisher & Paykel Healthcare Company Details 11.8.2 Fisher & Paykel Healthcare Business Overview 11.8.3 Fisher & Paykel Healthcare Hypersomnia Drug Introduction 11.8.4 Fisher & Paykel Healthcare Revenue in Hypersomnia Drug Business (2016-2021) 11.8.5 Fisher & Paykel Healthcare Recent Development 11.9 Drive Medical 11.9.1 Drive Medical Company Details 11.9.2 Drive Medical Business Overview 11.9.3 Drive Medical Hypersomnia Drug Introduction 11.9.4 Drive Medical Revenue in Hypersomnia Drug Business (2016-2021) 11.9.5 Drive Medical Recent Development 11.10 Merck 11.10.1 Merck Company Details 11.10.2 Merck Business Overview 11.10.3 Merck Hypersomnia Drug Introduction 11.10.4 Merck Revenue in Hypersomnia Drug Business (2016-2021) 11.10.5 Merck Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Hypersomnia Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Provigil Table 3. Key Players of Xyrem Table 4. Key Players of Others Table 5. Global Hypersomnia Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Hypersomnia Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Hypersomnia Drug Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Hypersomnia Drug Market Share by Regions (2016-2021) Table 9. Global Hypersomnia Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Hypersomnia Drug Market Share by Regions (2022-2027) Table 11. Hypersomnia Drug Market Trends Table 12. Hypersomnia Drug Market Drivers Table 13. Hypersomnia Drug Market Challenges Table 14. Hypersomnia Drug Market Restraints Table 15. Global Hypersomnia Drug Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Hypersomnia Drug Market Share by Players (2016-2021) Table 17. Global Top Hypersomnia Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hypersomnia Drug as of 2020) Table 18. Ranking of Global Top Hypersomnia Drug Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Hypersomnia Drug Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Hypersomnia Drug Product Solution and Service Table 22. Date of Enter into Hypersomnia Drug Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Hypersomnia Drug Market Size by Type (2016-2021) (US$ Million) Table 25. Global Hypersomnia Drug Revenue Market Share by Type (2016-2021) Table 26. Global Hypersomnia Drug Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Hypersomnia Drug Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Hypersomnia Drug Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Hypersomnia Drug Revenue Market Share by Application (2016-2021) Table 30. Global Hypersomnia Drug Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Hypersomnia Drug Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Hypersomnia Drug Market Size by Type (2016-2021) (US$ Million) Table 33. North America Hypersomnia Drug Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Hypersomnia Drug Market Size by Application (2016-2021) (US$ Million) Table 35. North America Hypersomnia Drug Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Hypersomnia Drug Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Hypersomnia Drug Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Hypersomnia Drug Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Hypersomnia Drug Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Hypersomnia Drug Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Hypersomnia Drug Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Hypersomnia Drug Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Hypersomnia Drug Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Hypersomnia Drug Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Hypersomnia Drug Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Hypersomnia Drug Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Hypersomnia Drug Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Hypersomnia Drug Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Hypersomnia Drug Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Hypersomnia Drug Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Hypersomnia Drug Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Hypersomnia Drug Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Hypersomnia Drug Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Hypersomnia Drug Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Hypersomnia Drug Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Hypersomnia Drug Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Hypersomnia Drug Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Hypersomnia Drug Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Hypersomnia Drug Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Hypersomnia Drug Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Hypersomnia Drug Market Size by Country (2022-2027) & (US$ Million) Table 62. Teva Company Details Table 63. Teva Business Overview Table 64. Teva Hypersomnia Drug Product Table 65. Teva Revenue in Hypersomnia Drug Business (2016-2021) & (US$ Million) Table 66. Teva Recent Development Table 67. Jazz Pharmaceuticals Company Details Table 68. Jazz Pharmaceuticals Business Overview Table 69. Jazz Pharmaceuticals Hypersomnia Drug Product Table 70. Jazz Pharmaceuticals Revenue in Hypersomnia Drug Business (2016-2021) & (US$ Million) Table 71. Jazz Pharmaceuticals Recent Development Table 72. BIOPROJET Company Details Table 73. BIOPROJET Business Overview Table 74. BIOPROJET Hypersomnia Drug Product Table 75. BIOPROJET Revenue in Hypersomnia Drug Business (2016-2021) & (US$ Million) Table 76. BIOPROJET Recent Development Table 77. AVADEL PHARMACEUTICALS Company Details Table 78. AVADEL PHARMACEUTICALS Business Overview Table 79. AVADEL PHARMACEUTICALS Hypersomnia Drug Product Table 80. AVADEL PHARMACEUTICALS Revenue in Hypersomnia Drug Business (2016-2021) & (US$ Million) Table 81. AVADEL PHARMACEUTICALS Recent Development Table 82. GlaxoSmithKline Company Details Table 83. GlaxoSmithKline Business Overview Table 84. GlaxoSmithKline Hypersomnia Drug Product Table 85. GlaxoSmithKline Revenue in Hypersomnia Drug Business (2016-2021) & (US$ Million) Table 86. GlaxoSmithKline Recent Development Table 87. Pfizer Company Details Table 88. Pfizer Business Overview Table 89. Pfizer Hypersomnia Drug Product Table 90. Pfizer Revenue in Hypersomnia Drug Business (2016-2021) & (US$ Million) Table 91. Pfizer Recent Development Table 92. Theranexus Company Details Table 93. Theranexus Business Overview Table 94. Theranexus Hypersomnia Drug Product Table 95. Theranexus Revenue in Hypersomnia Drug Business (2016-2021) & (US$ Million) Table 96. Theranexus Recent Development Table 97. Fisher & Paykel Healthcare Company Details Table 98. Fisher & Paykel Healthcare Business Overview Table 99. Fisher & Paykel Healthcare Revenue in Hypersomnia Drug Business (2016-2021) & (US$ Million) Table 100. Fisher & Paykel Healthcare Recent Development Table 101. Drive Medical Company Details Table 102. Drive Medical Business Overview Table 103. Drive Medical Hypersomnia Drug Product Table 104. Drive Medical Revenue in Hypersomnia Drug Business (2016-2021) & (US$ Million) Table 105. Drive Medical Recent Development Table 106. Merck Company Details Table 107. Merck Business Overview Table 108. Merck Hypersomnia Drug Product Table 109. Merck Revenue in Hypersomnia Drug Business (2016-2021) & (US$ Million) Table 110. Merck Recent Development Table 111. Research Programs/Design for This Report Table 112. Key Data Information from Secondary Sources Table 113. Key Data Information from Primary Sources List of Figures Figure 1. Global Hypersomnia Drug Market Share by Type: 2020 VS 2027 Figure 2. Provigil Features Figure 3. Xyrem Features Figure 4. Others Features Figure 5. Global Hypersomnia Drug Market Share by Application: 2020 VS 2027 Figure 6. Hospital Pharmacies Case Studies Figure 7. Retail Pharmacies Case Studies Figure 8. Online Pharmacies Case Studies Figure 9. Hypersomnia Drug Report Years Considered Figure 10. Global Hypersomnia Drug Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Hypersomnia Drug Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Hypersomnia Drug Market Share by Regions: 2020 VS 2027 Figure 13. Global Hypersomnia Drug Market Share by Regions (2022-2027) Figure 14. Global Hypersomnia Drug Market Share by Players in 2020 Figure 15. Global Top Hypersomnia Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hypersomnia Drug as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Hypersomnia Drug Revenue in 2020 Figure 17. Global Hypersomnia Drug Revenue Market Share by Type (2016-2021) Figure 18. Global Hypersomnia Drug Revenue Market Share by Type (2022-2027) Figure 19. North America Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Hypersomnia Drug Market Share by Type (2016-2027) Figure 21. North America Hypersomnia Drug Market Share by Application (2016-2027) Figure 22. North America Hypersomnia Drug Market Share by Country (2016-2027) Figure 23. United States Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Hypersomnia Drug Market Share by Type (2016-2027) Figure 27. Europe Hypersomnia Drug Market Share by Application (2016-2027) Figure 28. Europe Hypersomnia Drug Market Share by Country (2016-2027) Figure 29. Germany Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Hypersomnia Drug Market Share by Type (2016-2027) Figure 37. Asia-Pacific Hypersomnia Drug Market Share by Application (2016-2027) Figure 38. Asia-Pacific Hypersomnia Drug Market Share by Region (2016-2027) Figure 39. China Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Hypersomnia Drug Market Share by Type (2016-2027) Figure 47. Latin America Hypersomnia Drug Market Share by Application (2016-2027) Figure 48. Latin America Hypersomnia Drug Market Share by Country (2016-2027) Figure 49. Mexico Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Hypersomnia Drug Market Share by Type (2016-2027) Figure 53. Middle East & Africa Hypersomnia Drug Market Share by Application (2016-2027) Figure 54. Middle East & Africa Hypersomnia Drug Market Share by Country (2016-2027) Figure 55. Turkey Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Teva Revenue Growth Rate in Hypersomnia Drug Business (2016-2021) Figure 59. Jazz Pharmaceuticals Revenue Growth Rate in Hypersomnia Drug Business (2016-2021) Figure 60. BIOPROJET Revenue Growth Rate in Hypersomnia Drug Business (2016-2021) Figure 61. AVADEL PHARMACEUTICALS Revenue Growth Rate in Hypersomnia Drug Business (2016-2021) Figure 62. GlaxoSmithKline Revenue Growth Rate in Hypersomnia Drug Business (2016-2021) Figure 63. Pfizer Revenue Growth Rate in Hypersomnia Drug Business (2016-2021) Figure 64. Theranexus Revenue Growth Rate in Hypersomnia Drug Business (2016-2021) Figure 65. Fisher & Paykel Healthcare Revenue Growth Rate in Hypersomnia Drug Business (2016-2021) Figure 66. Drive Medical Revenue Growth Rate in Hypersomnia Drug Business (2016-2021) Figure 67. Merck Revenue Growth Rate in Hypersomnia Drug Business (2016-2021) Figure 68. Bottom-up and Top-down Approaches for This Report Figure 69. Data Triangulation Figure 70. Key Executives Interviewed

Teva Jazz Pharmaceuticals BIOPROJET AVADEL PHARMACEUTICALS GlaxoSmithKline Pfizer Theranexus Fisher & Paykel Healthcare Drive Medical Merck